High Mortality Rates in Patients With Thoracic Cancer and COVID-19
Patients with thoracic cancer and COVID-19 had a high mortality rate and were frequently not offered intensive care in the global TERAVOLT registry.
Diagnosis & Disease Information
ctDNA Biomarker of Relapse After Resection in Early NSCLC
A ctDNA test identified patients who would develop early relapse after surgical resection of stage I to III NSCLC.
cfDNA Test May Detect Disease Among Patients Who Are Suspected of Having Cancer
A test using plasma cfDNA detected cancer in patients who were suspected to have cancer, and was able to predict tissue of origin among patients with confirmed cancer.
Multicancer Liquid Biopsy Test May Identify Cancer in Older Women
A multicancer liquid biopsy test identified multiple cancer types in older women with no history of cancer, according to a prospective study of nearly 10,000 women.
First-in-Human Universal CAR-T Therapy Found Active in Relapsed/Refractory T-ALL
A first-in-human, universal CAR-T therapy was tolerable and showed activity against relapsed/refractory T-ALL in a phase 1 study.
Novel Bispecific CD19/CD22 CAR-T Therapy Deemed Tolerable in Relapsed/Refractory ALL
A novel, bispecific CD19/CD22 CAR-T therapy was tolerable and led to responses in a phase 1, dose-escalating study.
Racial and Ethnic Disparities Among Patients With Cancer and COVID-19
Racial and ethnic disparities have emerged among patients with cancer and COVID-19, with black and Hispanic populations experiencing disproportionality high mortality rates.
A Look at One Institution’s Approach To Cancer Care During the COVID-19 Pandemic
An institution in Italy has adapted their cancer care model to minimize the risk to patients and health care workers, while still prioritizing patients with cancer.
COVID-19 Not More Aggressive in French Cancer Patient Population
Patients with cancer did not demonstrate a more aggressive or lethal COVID-19 disease course in a French population.
Study Suggests Cancer Is Associated With Poor COVID-19 Outcomes
Patients with cancer who contracted COVID-19 demonstrated an aggressive presentation and poor outcomes, according to a retrospective study from Wuhan.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...